World Health Organization

More than 80 per cent of genomic studies across the world looking into diseases are concentrated in high-income countries, and under five per cent in low and middle-income countries, according to a new global analysis by the World Health Organization (WHO). More than 6,500 genomic clinical studies were registered globally between 1990 and 2024 via the WHO's International Clinical Trials Registry Platform, with a steep rise after 2010 driven by advances in sequencing technologies, lower costs and wider applications, it said. China led the list of top ten countries ranked by total number of genomic clinical studies registered over the past three decades, followed by the United States and Italy. India featured among the top 20 countries. "Fewer than five per cent of all studies were conducted in lower middle-income and low-income countries combined, while high-income countries accounted for over 80 per cent of all genomic studies," authors of the 'Human genomics technologies in clinica

The downsizing at the World Health Organization is part of a wider restructuring effort after the US decides to withdraw as its largest contributor

With diabetes complicating millions of pregnancies each year, the WHO outlines new global guidance on diet, monitoring and treatment to improve safety for mothers and babies

The WHO's Global Tuberculosis Report 2025 shows the first decline in cases since Covid, but warns that shrinking funding and persistent risks could undo gains against the world's deadliest infection

India made strong gains in TB reduction, cutting incidence by 21% since 2015, but still accounted for 25% of global cases in 2024, according to the WHO's Global TB Report 2025

WHO reports 2,862 cases and 17 deaths across 17 African nations in six weeks; new clade Ib strain detected in Europe and US, prompting renewed vigilance amid signs of local transmission

Despite improvements in water access, India lags behind BRICS peers in sanitation and school hygiene facilities, UNICEF data shows

CDSCO had earlier informed the global health body that none of the syrups were exported to other countries

The WHO's latest data show bacteria are evolving rapidly, outsmarting modern drugs, with South Asia and West Asia among the worst-hit regions as antibiotic resistance soars

The WHO identified specific batches of Coldrif (Sresan Pharmaceuticals), ReLife (Shape Pharma), and Respifresh TR (Rednex Pharmaceuticals) as contaminated

On World Mental Health Day 2025, experts highlight how awareness, balance and early support can protect well-being, especially during humanitarian crises

The children died over the past month after consuming cough medicine containing toxic diethylene glycol in quantities nearly 500 times the permissible limit

Published in Nature Medicine, the WHO review shows most clinical trials are concentrated in rich countries and ignore the deadliest cancers in low-income regions

India's infant mortality rate hits a record low, but stark regional gaps in nutrition, immunisation, and newborn care threaten to slow public health gains

From cancer drugs to diabetes therapies, WHO's new list expands access to modern medicines and boosts the push for global healthcare equity

WHO has lifted the global health emergency status on Mpox after a steady decline in cases, but it has warned nations to remain alert and safeguard vulnerable groups

WHO adds GLP-1 drugs for type 2 diabetes to its Essential Medicines List, as Indian pharma firms prepare to launch generics amid surging demand and patent expirations

The new WHO guidelines offer evidence-based protocols for managing dengue, chikungunya, Zika and yellow fever, aiming to improve diagnosis, care and epidemic preparedness worldwide

The WHO release follows India's proposal on the subject, leading to the development of WHO's first-ever roadmap for applying AI in traditional medicine

As Covid cases slowly rise again in India, the WHO's latest 2025-2030 roadmap and standing recommendations outline how countries should manage ongoing coronavirus risks without repeating past mistakes